Amarin Corp Plc (AMRN)

[dukesking]

North, thanks for sharing that info. It’s disappointing but not surprising as there’s many many medications being studied for CV19. I really don’t think Amarin is that far along in their investigation of Icosapent ethyl as a viable candidate as a trial or study medication. Management has certainly been coy and tight lipped about it.I think it was Terra Pharma that put out a list of all current medications being studied for CV19 treatments and vaccines and Icosapent ethyl wasn’t one of them at the time. I still hope to see a press release that states its use in some trial or study soon. I’ll be disappointed if it isn’t. Amarin has hinted that they’re fully aware of Vascepa’s obvious potential due to endothelial and cardiac damage caused by CV19. Fingers crossed.